Valeant CEO Pearson agrees to depose before Senate committee
April 13 (Reuters) - Valeant Pharmaceuticals International Inc's outgoing Chief Executive Michael Pearson will depose before the Senate Special Committee on Aging to comply with a congressional subpoena, the committee said.
Pearson will depose on April 18, ahead of an April 27 hearing, the committee said in a statement on Wednesday.
Valeant said on Monday that it had asked Pearson to cooperate with the committee after he failed to show up at a hearing on Friday related to an investigation into drug pricing. (Reporting by Ankur Banerjee in Bengaluru; Editing by Kirti Pandey)
© Thomson Reuters 2017 All rights reserved.